IP Library Assignment 045243/0819
Patent Assignment
Reel/Frame 045243/0819

Assignment of Assignor's Interest

Recorded: 2018-02-02 Pages: 6
Assignor
ZENITH CAPITAL CORP.
Executed: 2016-11-21
Assignee
ZENITH EPIGENETICS LTD.
300, 4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Novel Substituted Bicyclic Compounds as Bromodomain Inhibitors
Application: 15/492,838 →
Publication: US 2017/0216257
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2018
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; WANG, RUIFANG; JIANG, MAY XIAOWU
To: RVX THERAPEUTICS INC.
Reel/Frame 044822/0624 →
Assignment of Assignor's Interest Feb 2, 2018
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 045243/0809 →
Change of Name Feb 2, 2018
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 045243/0816 →
General Conveyance and Assumption Agreement Feb 2, 2018
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 045254/0058 →